In contrast to binding antibodies, nAb titers against all variants (ancestral, BA1, BA2, and BA5) were boosted after infection (post-infection) in all previously naïve individuals with a few exceptions (Fig. 3B; Table 4). The gene discussed is CD9; the disease is infection.